ALPN
Price
$64.58
Change
+$0.03 (+0.05%)
Updated
Apr 22, 6:59 PM EST
16 days until earnings call
RIGL
Price
$1.13
Change
+$0.05 (+4.63%)
Updated
Apr 22, 6:59 PM EST
7 days until earnings call
Ad is loading...

Analysis and predictions ALPN vs RIGL

Header iconALPN vs RIGL Comparison
Open Charts ALPN vs RIGLBanner chart's image
Alpine Immune Sciences
Price$64.58
Change+$0.03 (+0.05%)
Volume$682.88K
CapitalizationN/A
Rigel Pharmaceuticals
Price$1.13
Change+$0.05 (+4.63%)
Volume$574.89K
CapitalizationN/A
View a ticker or compare two or three
ALPN vs RIGL Comparison Chart

Loading...

ALPNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RIGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALPN vs. RIGL commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPN is a Hold and RIGL is a Hold.

COMPARISON
Comparison
Apr 23, 2024
Stock price -- (ALPN: $64.58 vs. RIGL: $1.13)
Brand notoriety: ALPN and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPN: 70% vs. RIGL: 212%
Market capitalization -- ALPN: $4.23B vs. RIGL: $196.45M
ALPN [@Biotechnology] is valued at $4.23B. RIGL’s [@Biotechnology] market capitalization is $196.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $557.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPN’s FA Score shows that 1 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • ALPN’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, ALPN is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPN’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • ALPN’s TA Score: 4 bullish, 4 bearish.
  • RIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALPN is a better buy in the short-term than RIGL.

Price Growth

ALPN (@Biotechnology) experienced а +0.25% price change this week, while RIGL (@Biotechnology) price change was -1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.60%. For the same industry, the average monthly price growth was -5.24%, and the average quarterly price growth was +1242.63%.

Reported Earning Dates

ALPN is expected to report earnings on Aug 13, 2024.

RIGL is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Biotechnology (-3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALPN with price predictions.
OPEN
A.I.dvisor published
a Summary for RIGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALPN($4.23B) has a higher market cap than RIGL($196M). ALPN YTD gains are higher at: 238.825 vs. RIGL (-22.069).
ALPNRIGLALPN / RIGL
Capitalization4.23B196M2,160%
EBITDAN/AN/A-
Gain YTD238.825-22.069-1,082%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALPN vs RIGL: Fundamental Ratings
ALPN
RIGL
OUTLOOK RATING
1..100
8951
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
3464
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPN's Valuation (72) in the Biotechnology industry is in the same range as RIGL (83). This means that ALPN’s stock grew similarly to RIGL’s over the last 12 months.

ALPN's Profit vs Risk Rating (2) in the Biotechnology industry is significantly better than the same rating for RIGL (100). This means that ALPN’s stock grew significantly faster than RIGL’s over the last 12 months.

ALPN's SMR Rating (93) in the Biotechnology industry is in the same range as RIGL (100). This means that ALPN’s stock grew similarly to RIGL’s over the last 12 months.

ALPN's Price Growth Rating (34) in the Biotechnology industry is in the same range as RIGL (64). This means that ALPN’s stock grew similarly to RIGL’s over the last 12 months.

ALPN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RIGL (100). This means that ALPN’s stock grew similarly to RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPNRIGL
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ALPNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RIGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MBOX30.660.23
+0.76%
Freedom Day Dividend ETF
ENOR23.370.17
+0.71%
iShares MSCI Norway ETF
RYLD16.210.11
+0.70%
Global X Russell 2000 Covered Call ETF
EMHC23.590.11
+0.48%
SPDR® Bloomberg EM USD Bd ETF
SZK14.17-0.25
-1.73%
ProShares UltraShort Consumer Staples

ALPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPN has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPN
1D Price
Change %
ALPN100%
+0.05%
AXON - ALPN
39%
Loosely correlated
+0.07%
VERA - ALPN
38%
Loosely correlated
+2.97%
ACLX - ALPN
34%
Loosely correlated
+0.68%
AURA - ALPN
34%
Loosely correlated
-1.39%
KOD - ALPN
34%
Loosely correlated
+1.79%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with AUTL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then AUTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+4.63%
AUTL - RIGL
37%
Loosely correlated
+0.88%
NTLA - RIGL
37%
Loosely correlated
+1.21%
RCUS - RIGL
35%
Loosely correlated
+0.62%
NRIX - RIGL
34%
Loosely correlated
-0.07%
XNCR - RIGL
33%
Loosely correlated
-0.92%
More